Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MDGL | Common Stock | Award | $0 | +714 | +0.19% | $0.00 | 375K | Jun 25, 2024 | Direct | F1 |
holding | MDGL | Common Stock | 11.2K | Jun 25, 2024 | See Footnote | F2 | |||||
holding | MDGL | Common Stock | 1.26K | Jun 25, 2024 | See Footnote | F3 | |||||
holding | MDGL | Common Stock | 18K | Jun 25, 2024 | See Footnote | F4 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MDGL | Stock Option (Right to Buy) | Award | $0 | +1.11K | $0.00 | 1.11K | Jun 25, 2024 | Common Stock | 1.11K | $280.04 | Direct | F5 |
Id | Content |
---|---|
F1 | Represents a grant of restricted stock units, which vest on June 25, 2025, provided the Reporting Person continues in service with the Issuer on such date. |
F2 | Represents shares held indirectly by Dr. Craves through a grantor retained annuity trust. |
F3 | These securities are held by Bay City Capital LLC ("BCC"). Dr. Craves disclaims beneficial ownership of these securities held by BCC, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in BCC. |
F4 | Represents shares held indirectly by Dr. Craves through the Craves Family Foundation. |
F5 | The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date. |